Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.715 USD | -4.25% | -9.05% | -0.53% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.53% | 442M | |
+3.40% | 106B | |
+7.02% | 23.47B | |
-14.72% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.22% | 16.78B | |
+5.25% | 14.41B | |
+37.52% | 12.86B | |
+329.10% | 8.78B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Goldman Sachs Adjusts Price Target on Fate Therapeutics to $4 From $10, Maintains Sell Rating